About
Antibody Therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
202
By Phase
PHASE1/PHASE2: 1PHASE1: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06249919Lead Sponsor
A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients
PHASE1/PHASE2Recruiting
138 participants
Started: Jan 19, 2024 · Completed: Jan 31, 2027
NCT05143463Lead Sponsor
A FIH Study to Assess the Safety and Tolerability of NS Intravenous NS101 Infusion
PHASE1Completed
64 participants
Started: Nov 4, 2021 · Completed: Dec 22, 2022
Locations (1)
Headquarters
Seoul, Korea
Map
Loading map...